Michigan Headache & Neurological Institute

What Michigan Headache & Neurological Institute does

Michigan Headache & Neurological Institute (MHNI) is a private, for-profit specialty medical center headquartered in Ann Arbor, Michigan, founded in 1978 by Dr. Joel R. Saper. It is the nation's first comprehensive head pain treatment and research center and the only head pain program nationally accredited by The Joint Commission. MHNI treats patients with chronic migraine, cluster headaches, tension headaches, face and neck pain, and related neurological disorders — including complex, treatment-resistant cases — using a multidisciplinary team of headache-certified physicians, PhD psychologists, pain anesthesiologists, physician assistants, physical therapists, and registered nurses. Services span outpatient care at its Ann Arbor campus (20 clinical examination rooms), an inpatient Headache Treatment Unit at St. Joseph Mercy Chelsea (the world's first hospital specialty program for headache, est. 1978), interventional pain procedures (nerve blocks, neurostimulation, radiofrequency ablation, cryoneurolysis, IDET, intrathecal drug delivery), behavioral medicine including biofeedback, physical therapy, on-site EEG/ECG diagnostics, sleep studies, and a Head Injury Program.

MHNI operates a dual revenue model combining clinical healthcare services and clinical research. Clinical revenue is generated from professional services billed through insurance, Medicare, and self-pay across outpatient and inpatient pathways (90% of patients are outpatient; ~30% require hospital services). Research revenue is generated through a Clinical Research Division that has conducted over 500 Phase I–IV trials since 1978 sponsored by major pharmaceutical companies (Abbott, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer) and medical device manufacturers (Boston Scientific, Medtronic, St. Jude Medical), supported by dedicated RN coordinators, central IRB access, an on-site lab, and EDC capability. Patient acquisition is primarily referral-led (healthcare providers preferred but not required), supplemented by a self-referral web channel, phone nurse access, educational content marketing, and out-of-region travel planning services that suggest national patient flow into a tri-state primary catchment (southeast Michigan, northwest Ohio, northeast Indiana; population base over 6 million). The institute delivers over 20,000 visits per year, operates from two physical locations, employs 101–250 staff, and is privately held and controlled by its founder.

Name

Michigan Headache & Neurological Institute

Legal name

Michigan Headache & Neurological Institute

Website

https://mhni.com

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

101–250 employees

Short description

Michigan Headache & Neurological Institute is a private Ann Arbor-based specialty medical center founded in 1978 that diagnoses and treats chronic head, face, and neck pain through multidisciplinary outpatient care, inpatient services, interventional procedures, and a clinical research division running 500+ trials.

Ownership category

akta.pro rank

Product category

Headache and Neurological Care

NAICS

Ambulatory Health Care Services (621), Other Ambulatory Health Care Services (6219), Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Headache & Migraine Medicine (HLAKAIAE)

akta.pro secondary industries

Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM), Pain Management Clinics (Interventional & Medical) (HLAFABAH)

Keywords

• Headache treatment services
• Neurological pain care
• Interventional pain procedures
• Behavioral pain medicine
• Clinical research trials

Headquarters

HQ city

Ann Arbor

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Healthcare Services: Revenue generated from patient visits, diagnostic services, interventional procedures, and hospital services. Billed through insurance, Medicare, or self-pay. Includes outpatient treatment (90% of patients) and inpatient hospital treatment at St. Joseph Mercy Chelsea (approximately 30% of patients require hospital services).
2. Clinical Research Trials: Conducting clinical trials for pharmaceutical and medical device companies. The institute has conducted over 500 research studies since 1978 with sponsors including major pharmaceutical companies.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Michigan Headache & Neurological Institute provides comprehensive multidisciplinary clinical care for patients suffering from chronic head pain, migraine, face pain, neck pain, and related neurological disorders. Services are delivered through an outpatient facility in Ann Arbor serving approximately 90% of patients and an inpatient Headache Treatment Unit at St. Joseph Mercy Chelsea, complemented by interventional procedures, behavioral medicine, physical therapy, neurodiagnostic testing, and a Clinical Research Division that has conducted over 500 trials since 1978.

Product overview

Michigan Headache & Neurological Institute offers a comprehensive portfolio of healthcare services centered on head pain, face pain, neck pain, and related neurological disorders. The core offerings include Outpatient Treatment (serving approximately 90% of patients at their Ann Arbor facility), the Inpatient Headache Treatment Unit at St. Joseph Mercy Chelsea (the world's first hospital specialty program for headache patients), and Procedural/Surgical Services (ten interventional techniques including nerve blocks, cryoneurolysis, radiofrequency ablation, neurostimulation, and intrathecal drug delivery). Supporting services include Medical Care, Acute Care, Behavioral Medicine, Physical Therapy, Diagnostic Services (EEG/ECG), and a Head Injury Program. The institute also operates a Clinical Research Division conducting over 500 clinical trials since 1978, offering overnight polysomnography and specialized research services to pharmaceutical and medical device sponsors.

Differentiator

Problem solved

Functional benefit

Products and services

• Outpatient Treatment Comprehensive multidisciplinary outpatient clinical services for head pain, face pain, neck pain, and related neurological disorders delivered at MHNI's Ann Arbor facility, serving approximately 90% of MHNI patients.
• Inpatient Treatment (Headache Treatment Unit) Hospital-based acute medical treatment program at St. Joseph Mercy Chelsea for patients with complex, intense, or persistent pain patterns unresponsive to outpatient care, including specialized nursing and monitoring.
• Procedural and Surgical Services Interventional pain techniques including Trigger Point Injection, Occipital Nerve Block, Cervical/Thoracic/Lumbar Epidural, Facet Block, Epidurogram, Cryoneurolysis, Radiofrequency Nerve Ablation, Neurostimulation Therapy, IntraDiscal ElectroThermal Therapy (IDET), and Intrathecal Drug Delivery for chronic headache and pain patients.
• Medical Care Multispecialty physician team from pain medicine, neurology, and anesthesiology addressing recurring, treatment-resistant, or complex pain conditions for MHNI patients.
• Acute Care Treatment for patients experiencing acute episodes of pain with special facilities, monitoring, nursing services, and advanced therapies at MHNI.
• Behavioral Medicine Psychological assessment and treatment services including psychotherapy, cognitive-behavioral therapy, and biofeedback for depression, anxiety, and stress related to chronic pain, delivered by PhD psychologists.
• Physical Therapy Evaluation and treatment for joints, ligaments, muscles, nerves, and soft tissue structures to restore function, eliminate movement restrictions, and reduce pain for MHNI patients.
• Diagnostic Services On-site neurodiagnostic testing including Electroencephalogram (EEG) and Electrocardiogram (ECG), performed by licensed technicians and interpreted by physician specialists at MHNI.
• Head Injury Program Specialized program for patients with head injuries and associated neurological conditions, integrated into MHNI's overall treatment offering.
• Clinical Research Division Clinical trial services for pharmaceutical and medical device sponsors across therapeutic areas including pediatric/adult migraine, cluster headache, neuropathic pain, fibromyalgia, insomnia, and general neurology, with dedicated RN coordinators, central IRB, onsite lab, and EDC capability; over 500 trials conducted since 1978.
• Overnight Polysomnography Sleep study services for diagnosing and treating sleep disorders associated with headache and pain conditions, provided through MHNI's specialized research services.

Quantifiable outcome

• 90% of patients treated successfully on outpatient basis
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• St. Joseph Mercy ChelseacoreStrategic or Co-development Partner · 1 January 1978MHNI developed the first hospital specialty program for headache patients in the world with St. Joseph Mercy Chelsea (formerly Chelsea Community Hospital) in 1978. The Headache Treatment Unit (HTU) became the pioneering model for specialized treatment of severe head, neck, and pain illnesses. St. Joseph Mercy Chelsea is a general acute care hospital located 15 miles west of Ann Arbor.
• Pharmaceutical Industry Sponsors (Abbott, Allergan, AstraZeneca, Pfizer, etc.)coreStrategic or Co-development PartnerSince 1978, MHNI has conducted hundreds of clinical trials with pharmaceutical industry sponsors including Abbott, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and many others. The institute conducts Phase I-IV clinical trials evaluating investigational medications for headache and pain disorders.
• Medical Device Partners (Boston Scientific, Medtronic, St. Jude Medical)coreStrategic or Co-development PartnerMHNI has conducted medical device trials with Boston Scientific, Medtronic, and St. Jude Medical, evaluating devices such as neurostimulation systems for chronic pain treatment.
• The Joint CommissioncoreOthersMHNI is the first (and only) head pain treatment program nationally accredited by The Joint Commission, demonstrating compliance with rigorous quality and safety standards.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Jefferson Headache Center (Thomas Jefferson University): Academic, multidisciplinary headache specialty center offering outpatient and inpatient headache care, interventional procedures, behavioral medicine, and clinical trials; directly comparable to MHNI in service mix and patient population.
• Johns Hopkins Headache Center: Academic headache center within Johns Hopkins providing comprehensive evaluation and treatment of primary and secondary headache disorders, including interventional options and clinical trials; comparable specialty model and tertiary referral positioning.
• Diamond Headache Clinic: Chicago-based historical headache specialty clinic (now affiliated with AMITA Health/Ascension) offering multidisciplinary headache and pain treatment; highly comparable to MHNI as one of the few standalone specialty headache centers in the U.S. with research capabilities.
• Mass General Brigham - John R. Graham Headache Center: Multidisciplinary academic headache center at Massachusetts General Hospital offering medical, behavioral, and interventional headache therapies plus clinical research; directly comparable patient population and service breadth.
• UCLA Goldberg Migraine Program: Specialty migraine and headache program at UCLA offering multidisciplinary evaluation, treatment, and research for complex headache patients; directly comparable in clinical model and research orientation.
• NYU Langone Headache Center: Academic multidisciplinary headache program with neurology, pain, and behavioral specialists treating migraine, cluster, and treatment-resistant headaches; comparable to MHNI in clinical model and research-driven specialty focus.
• Stanford Headache Clinic: Academic, multidisciplinary headache specialty clinic offering outpatient headache and facial pain care with active clinical research; comparable in scope, expertise, and tertiary referral profile to MHNI.

Broad incumbents

• Mayo Clinic Department of Neurology: Large integrated health system's neurology department that includes headache specialty services; comparable as a tertiary headache referral destination with research capabilities, but operates as part of a much broader enterprise rather than a dedicated headache center.
• Cleveland Clinic Neurological Institute: Multi-specialty neurological institute including headache and facial pain services within a national health system; comparable in handling complex headache patients but differs by being embedded in a broader specialty hospital network.

Emerging players

• National Spine & Pain Centers: Large interventional pain management network offering nerve blocks, RFA, spinal cord stimulation, and related procedures; overlaps with MHNI's interventional pain services and outpatient procedural model, but focuses on spine/general pain rather than dedicated headache specialization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/michigan.headpain

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Michigan Headache & Neurological Institute